Skip to main content
. 2018 Jan 22;15(4):4093–4096. doi: 10.3892/ol.2018.7836

Figure 3.

Figure 3.

Heterozygous germline mutation in BRCA2 exon 17, c.7976G>A, p.(Arg2659Lys). (A-C) Demonstration of the loss of heterozygosity analysis in tumor cells (C), the heterozygous germline mutation (B) and a wild-type reference of a healthy predicted-negative relative (A).